Clinical Trial Update: Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the combination of zoledronic acid and radiotherapy for bone metastases in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastasis
• Non-small Cell Lung Cancer

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Conditions: Non-small Cell Lung Cancer, Bone Metastasis | Phase 4 | Status: UNKNOWN